Douglas Lorne Arnold, MD, FRCP(C)

Cituota

	Visi	Nuo 2020
Šaltiniai	61245	21473
h-rodyklė	127	66
i10-rodyklė	415	279

4400

2200

1100

3300

19911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025163 145 178 225 306 291 454 522 712 812 1076 1135 1076 1173 1356 1234 1278 1342 1334 1402 1368 1705 1984 2208 2376 2693 3100 3152 3448 3676 4320 4307 4186 4233 693

Viešas pasiekiamumas

Peržiūrėti viską

99 straipsniai

29 straipsniai

pasiekiami

nepasiekiami

Pagal finansavimo įpareigojimus

Bendraautoriai

Amit Bar-OrProfessor, University of PennsylvaniaPatvirtintas el. paštas pennmedicine.upenn.edu
Sridar Narayanan, PhDAssistant Professor: Department of Neurology and Neurosurgery, McGill UniversityPatvirtintas el. paštas mcgill.ca
Paul M. MatthewsEdmond and Lily Safra Chair, Professor of Clinical Neurosciences, Imperial College LondonPatvirtintas el. paštas imperial.ac.uk
D. Louis CollinsProfessor of Biomedical Engineering and Neurology & Neurosurgery, McGill UniversityPatvirtintas el. paštas mcgill.ca
Nicola De StefanoProfessor of Neurology, Universtiy of Siena,Patvirtintas el. paštas unisi.it
Gavin GiovannoniQueen Mary University of LondonPatvirtintas el. paštas giovannoni.net
Jerry S Wolinsky, MDEmeritus Professor in Neurology, McGovern Medical School, UTHealth, The University of Texas HealthPatvirtintas el. paštas uth.tmc.edu
Zografos CaramanosMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill UniversityPatvirtintas el. paštas mcgill.ca
Fernando CendesFull Professor, Department of Neurology, FCM, University of Campinas - UNICAMP, BrazilPatvirtintas el. paštas unicamp.br
Jeffrey A CohenCleveland ClinicPatvirtintas el. paštas ccf.org
Robert J FoxMellen Center for Multiple Sclerosis, Cleveland ClinicPatvirtintas el. paštas ccf.org
eric shoubridgeProfessor, Human Genetics, McGill UniversityPatvirtintas el. paštas ericpc.mni.mcgill.ca
Li Min LiProfessor of Neurology, Faculty of Medical Sciences at University of CampinasPatvirtintas el. paštas fcm.unicamp.br
Robert A BrownUniversity of Calgary; Montreal Neurological Institute; ShadowLab Research Inc.Patvirtintas el. paštas shadowlabresearch.com
Bruce PikeCAIP Chair in Healthy Brain Aging, Head of Image Science, Professor - U of CalgaryPatvirtintas el. paštas ucalgary.ca
John G. SledSenior Scientist, Hospital for Sick Children / Professor, University of TorontoPatvirtintas el. paštas utoronto.ca
Emmanuelle WaubantProfessor of Neurology and PediatricsPatvirtintas el. paštas ucsf.edu
Colm ElliottNeuroRx ResearchPatvirtintas el. paštas neurorx.com
Alasdair ColesUniversity of CambridgePatvirtintas el. paštas medschl.cam.ac.uk
Tal ArbelProfessor of Electrical & Computer Engineering, McGill UniversityPatvirtintas el. paštas cim.mcgill.ca

Stebėti

Douglas Lorne Arnold, MD, FRCP(C)

James McGill Professor: Department of Neurology and Neurosurgery, Faculty of Medicine, McGill

Patvirtintas el. paštas mcgill.ca - Pagrindinis puslapis

Magnetic Resonance Imaging Neurological Disorders Multiple Sclerosis Alzheimer's Disease


Pavadinimas Rūšiuoti pagal šaltinius Rūšiuoti pagal metus Rūšiuoti pagal pavadinimą	Cituota Cituota	Metai
B-cell depletion with rituximab in relapsing–remitting multiple sclerosis SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ... New England Journal of Medicine 358 (7), 676-688, 2008	2862	2008
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ... N Engl J Med 376 (3), 209-220, 2017	2132	2017
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ... New England Journal of Medicine 367 (12), 1098-1107, 2012	2128	2012
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ... N Engl J Med 376 (3), 221-234, 2017	2050	2017
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial JA Cohen, AJ Coles, DL Arnold, C Confavreux, EJ Fox, HP Hartung, ... The Lancet 380 (9856), 1819-1828, 2012	1326	2012
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial AJ Coles, CL Twyman, DL Arnold, JA Cohen, C Confavreux, EJ Fox, ... The lancet 380 (9856), 1829-1839, 2012	1307	2012
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P ... Lancet 391 (10127), 1263-1273, 2018	1077	2018
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability N De Stefano, S Narayanan, GS Francis, R Arnaoutelis, MC Tartaglia, ... Archives of neurology 58 (1), 65-70, 2001	686	2001
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy MC Preul, Z Caramanos, DL Collins, JG Villemure, R Leblanc, A Olivier, ... Nature medicine 2 (3), 1996	682	1996
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: Results of a longitudinal magnetic resonance spectroscopy study N De Stefano, PM Matthews, L Fu, S Narayanan, J Stanley, GS Francis, ... Brain 121 (Pt 8), 1469-1477, 1998	629	1998
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ... Annals of neurology 63 (3), 395-400, 2008	616	2008
Imaging axonal damage of normal-appearing white matter in multiple sclerosis L Fu, PM Matthews, N De Stefano, KJ Worsley, S Narayanan, GS Francis, ... Brain 121 (1), 103-113, 1998	608	1998
Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region N Bernasconi, A Bernasconi, Z Caramanos, SB Antel, F Andermann, ... Brain 126 (2), 462-469, 2003	592	2003
Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR DL Arnold, PM Matthews, GK Radda Magnetic resonance in medicine 1 (3), 307-315, 1984	581	1984
Reversible decreases in N‐acetylaspartate after acute brain injury ND Stefano, PM Matthews, DL Arnold Magnetic Resonance in Medicine 34 (5), 721-727, 1995	539	1995
Exploring uncertainty measures in deep networks for Multiple sclerosis lesion detection and segmentation AT Nair T, Precup D, Arnold DL Med Image Anal 59, 101557, 2020	524	2020
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study PA Calabresi, BC Kieseier, DL Arnold, LJ Balcer, A Boyko, J Pelletier, ... The Lancet Neurology 13 (7), 657-665, 2014	477	2014
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled … Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Wang Q, Bernasconi C, Model ... JAMA Neurol [PMID: 32511687; Epub: 2020/06/09] 77 (9), 1132-1140, 2020	474*	2020
Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging D Garcia-Lorenzo, S Francis, S Narayanan, DL Arnold, DL Collins Medical image analysis 17 (1), 1-18, 2013	464	2013
Incidence of acquired demyelination of the CNS in Canadian children B Banwell, J Kennedy, D Sadovnick, DL Arnold, S Magalhaes, ... Neurology 72 (3), 232-239, 2009	423	2009

Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.

Straipsniai 1–20

Šaltinių per metus

Dubliuoti šaltiniai

Sujungti šaltiniai

Pridėti bendraautoriusBendraautoriai

Stebėti

Cituota

Bendraautoriai